---
title: Acupuncture for the Treatment of Posttraumatic Stress Among Military Personnel
nct_id: NCT00320138
overall_status: COMPLETED
phase: PHASE1
sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine
study_type: INTERVENTIONAL
primary_condition: Posttraumatic Stress Disorder (PTSD)
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT00320138.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT00320138"
ct_last_update_post_date: 2012-01-12
last_seen_at: "2026-05-12T07:31:16.785Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Acupuncture for the Treatment of Posttraumatic Stress Among Military Personnel

**Official Title:** Acupuncture for the Treatment of Trauma Survivors

**NCT ID:** [NCT00320138](https://clinicaltrials.gov/study/NCT00320138)

## Key Facts

- **Status:** COMPLETED
- **Phase:** PHASE1
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 55
- **Lead Sponsor:** Henry M. Jackson Foundation for the Advancement of Military Medicine
- **Collaborators:** Federal government (congressional allocation)
- **Conditions:** Posttraumatic Stress Disorder (PTSD)
- **Start Date:** 2006-03
- **Completion Date:** 2007-10
- **CT.gov Last Update:** 2012-01-12

## Brief Summary

The purpose of this study is to determine the effectiveness of acupuncture as a treatment for Posttraumatic Stress Disorder (PTSD) among military personnel.

## Detailed Description

Untreated Posttraumatic Stress Disorder (PTSD) leads to decreased force readiness and increased health care utilization. Yet, service members with the disorder may be resistant to traditional treatments or find them undesirable because of side-effects, stigma, and long-term commitment. Acupuncture, which has few known side effects, holds promise as an effective treatment option for PTSD. Acupuncture has been shown to improve well-being and has been successfully used to treat stress, anxiety and pain conditions. In order to test the efficacy of acupuncture for treating the symptoms of PTSD-measured by the PTSD Checklist (PCL)-a 12-week, randomized, waitlist-controlled trial will be conducted using a sample of 75 active duty military personnel. Participants will receive an eight-session acupuncture treatment, and will be evaluated throughout the study by way of clinical assessments and an independent assessing acupuncturist.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 60 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Active duty military personnel
* Criteria met for PTSD based on Clinician-Administered PTSD Scale (CAPS) interview
* A stable medication dosing regimen or therapeutic treatment schedule for at least eight (8) weeks prior to beginning the study.

Exclusion Criteria:

* Acupuncture treatment within the previous 6 months
* Pain greater than or equal to level 8 on the Numeric Rating Scale for Pain
* Significant head injury with loss of consciousness greater than 1 hour
* Uncontrolled diabetes mellitus: fasting blood glucose \>180 mg/dl
* Unstable or uncontrolled endocrine disorders, thyroid disease, renal failure, anemia, hemorrhagic diathesis, renovascular disease, Cushing's disease, or hyperaldosteronism
* Unwillingness on the part of participants to complete all study visits and/or the daily Life Chart
* Pregnancy
* Scheduled surgery during the treatment phase of the study
* Medical instability sufficient to warrant inpatient treatment in the medical or intensive care units
* Psychiatric symptoms sufficient to warrant inpatient treatment by the clinical care team
* Psychosis within the past two years
* A traumatic experience, as defined by the DSM-IV criterion A for ASD/PTSD, within the past 30 days
```

## Arms

- **Acupuncture** (ACTIVE_COMPARATOR)
- **Wait List** (NO_INTERVENTION) — Usual Care

## Interventions

- **Acupuncture, using Chinese Medicine methodology** (PROCEDURE) — 4 weeks of 2/week treatments (8 total); 4 standardized and 4 individualized treatments

## Primary Outcomes

- **PTSD Checklist (PCL)** _(time frame: baseline, 1 month, 2 months, and 3 months)_ — The PCL is a widely used measure of PTSD symptom presence and severity among veterans. It is a 17-item measure that assesses the symptoms of PTSD listed in the DSM-IV. Respondents indicate on a 5-point scale (1-5) the degree to which they have been bothered by each symptom in the past month. The PCL-M yields a total severity score ranging from 17 to 85.

## Secondary Outcomes

- **Clinician-Administered PTSD Scale** _(time frame: baseline, 3 months)_
- **The Trauma History Questionnaire** _(time frame: baseline, 3 months)_
- **SF-36-Revised** _(time frame: baseline, 3 months)_
- **Beck Depression Inventory** _(time frame: baseline, 1 month, 2 months, 3 months)_
- **Numeric Rating Scale for Pain** _(time frame: baseline, 1 month, 2 months, 3 months)_
- **PTSD Life Chart Method (PTSD-LCM)** _(time frame: tracked daily throughout 3-month study period)_
- **Alcohol Use Disorder Identification Test** _(time frame: baseline, 3 months)_
- **Diagnostic evaluation by blind assessing acupuncturist** _(time frame: baseline, 1 month)_

## Locations (1)

- Deployment Health Clinical Center, WRNMMC/USUHS Dept. of Psychiatry, Bethesda, Maryland, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.deployment health clinical center, wrnmmc/usuhs dept. of psychiatry|bethesda|maryland|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT00320138.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT00320138*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*